Title:
バクテリオファージ・ラムダ・インテグラーゼの変異体
Document Type and Number:
Japanese Patent JP6616822
Kind Code:
B2
Abstract:
The present invention refers to lambda integrases comprising at least one amino acid mutation at positions 43, 319 and 336 of the lambda integrase as set forth in SEQ ID NO: 1. The invention further refers to nucleic acid molecules comprising the nucleotide sequence encoding the mutant lambda integrase and to host cells containing these nucleic acid molecules. The invention also refers to methods of recombining a nucleic acid of interest into a target nucleic acid in the presence of the mutant lambda integrase and sequence specific recombination kits.
Inventors:
Gaddessie, Farid
Shaw, Ja Wei
Drogue, Peter
Makija and Harsha
Vijaya Chandra, Shree Harsha
Peter, Sabrina
Shaw, Ja Wei
Drogue, Peter
Makija and Harsha
Vijaya Chandra, Shree Harsha
Peter, Sabrina
Application Number:
JP2017506963A
Publication Date:
December 04, 2019
Filing Date:
August 11, 2015
Export Citation:
Assignee:
Agency for Science, Technology and Research
International Classes:
C12N15/34; C12N9/12
Foreign References:
| US20130017578 |
Other References:
Nucleic Acids Research,2010年,38(4),e25
J. Mol. Biol.,1995年,252,178-188
J. Mol. Biol.,1995年,252,178-188
Attorney, Agent or Firm:
Suzue International Patent Office